Dare Bioscience, Inc. Basic Shares Outstanding (Weighted Average)
Dare Bioscience, Inc. (DARE) reported Basic Shares Outstanding (Weighted Average) of 14.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 14.89M shares, a 67.85% increase year-over-year.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 14.52M shares, a 65.80% increase year-over-year.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 14.29M shares, a 78.14% increase year-over-year.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 12.76M shares, a 49.45% increase year-over-year.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 11.18M shares, a 31.55% increase from fiscal 2024.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 8.50M shares, a 16.80% increase from fiscal 2023.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 7.28M shares, a 91.40% decline from fiscal 2022.
- Dare Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 84.57M shares, a 38.29% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 14.89M shares 10-Q · filed 2026-08-13 | 14.71M shares 10-Q · filed 2026-08-13 | 14.57M shares derived: average of 3 quarters · filed 2026-08-13 | 14.11M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 14.52M shares 10-Q · filed 2026-05-14 | 14.40M shares derived: average of 2 quarters · filed 2026-05-14 | 13.85M shares derived: average of 3 quarters · filed 2026-05-14 | 12.61M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 14.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 13.52M shares derived: average of 2 quarters · filed 2026-03-26 | 11.97M shares derived: average of 3 quarters · filed 2026-08-13 | 11.18M shares 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | 12.76M shares 10-Q · filed 2025-11-13 | 10.81M shares derived: average of 2 quarters · filed 2026-08-13 | 10.14M shares 10-Q · filed 2025-11-13 | 9.60M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 8.87M shares 10-Q · filed 2026-08-13 | 8.82M shares 10-Q · filed 2026-08-13 | 8.55M shares derived: average of 3 quarters · filed 2026-08-13 | 8.55M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 8.76M shares 10-Q · filed 2026-05-14 | 8.39M shares derived: average of 2 quarters · filed 2026-05-14 | 8.44M shares derived: average of 3 quarters · filed 2026-05-14 | 8.43M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 8.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 8.28M shares derived: average of 2 quarters · filed 2026-03-26 | 8.32M shares derived: average of 3 quarters · filed 2026-03-26 | 8.50M shares 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | 8.53M shares 10-Q · filed 2025-11-13 | 8.47M shares derived: average of 2 quarters · filed 2025-11-13 | 8.66M shares 10-Q · filed 2025-11-13 | 8.15M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 8.41M shares 10-Q · filed 2025-08-14 | 8.46M shares 10-Q · filed 2025-08-14 | 8.03M shares derived: average of 3 quarters · filed 2025-08-14 | 7.92M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 8.38M shares 10-Q · filed 2025-05-13 | 100.51M shares 10-Q · filed 2024-05-14 | 7.84M shares derived: average of 2 quarters · filed 2025-05-13 | 7.75M shares derived: average of 3 quarters · filed 2025-05-13 | 7.61M shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 7.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 7.44M shares derived: average of 2 quarters · filed 2025-03-31 | 7.36M shares derived: average of 3 quarters · filed 2025-03-31 | 7.28M shares 10-K · filed 2025-03-31 | 87.30M shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 7.59M shares 10-Q · filed 2024-11-14 | 91.05M shares 10-Q · filed 2023-11-09 | 7.39M shares derived: average of 2 quarters · filed 2024-11-14 | 7.27M shares 10-Q · filed 2024-11-14 | 87.22M shares 10-Q · filed 2023-11-09 | 45.48M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 7.20M shares 10-Q · filed 2024-08-12 | 86.40M shares 10-Q · filed 2023-08-10 | 7.25M shares 10-Q · filed 2024-08-12 | 86.98M shares 10-Q · filed 2023-08-10 | 58.12M shares derived: average of 3 quarters · filed 2024-08-12 | 64.79M shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 85.52M shares 10-Q · filed 2024-05-14 | 83.57M shares derived: average of 2 quarters · filed 2024-05-14 | 83.99M shares derived: average of 3 quarters · filed 2024-05-14 | 84.16M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 81.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 83.23M shares derived: average of 2 quarters · filed 2024-03-28 | 83.71M shares derived: average of 3 quarters · filed 2024-03-28 | 84.57M shares 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | 84.82M shares 10-Q · filed 2023-11-09 | 84.75M shares derived: average of 2 quarters · filed 2023-11-09 | 85.55M shares 10-Q · filed 2023-11-09 | 76.37M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 84.68M shares 10-Q · filed 2023-08-10 | 84.68M shares 10-Q · filed 2023-08-10 | 73.55M shares derived: average of 3 quarters · filed 2023-08-10 | 72.86M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 83.94M shares 10-Q · filed 2023-05-11 | 67.99M shares derived: average of 2 quarters · filed 2023-05-11 | 68.92M shares derived: average of 3 quarters · filed 2023-05-11 | 64.30M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 52.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 61.40M shares derived: average of 2 quarters · filed 2023-03-30 | 57.75M shares derived: average of 3 quarters · filed 2023-03-30 | 61.15M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 70.78M shares 10-Q · filed 2022-11-10 | 60.61M shares derived: average of 2 quarters · filed 2022-11-10 | 64.20M shares 10-Q · filed 2022-11-10 | 50.98M shares derived: average of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | 50.44M shares 10-Q · filed 2022-08-09 | 47.49M shares 10-Q · filed 2022-08-09 | 44.39M shares derived: average of 3 quarters · filed 2022-08-09 | 41.19M shares derived: average of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | 44.50M shares 10-Q · filed 2022-05-12 | 41.36M shares derived: average of 2 quarters · filed 2022-05-12 | 38.10M shares derived: average of 3 quarters · filed 2022-05-12 | 35.26M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | 38.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 34.90M shares derived: average of 2 quarters · filed 2022-03-31 | 32.17M shares derived: average of 3 quarters · filed 2022-03-31 | 30.09M shares 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 31.59M shares 10-Q · filed 2021-11-10 | 29.15M shares derived: average of 2 quarters · filed 2021-11-10 | 27.38M shares 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | 26.71M shares 10-Q · filed 2021-08-12 | 25.26M shares 10-Q · filed 2021-08-12 | ||||||
| 2018-06-30 | 11.42M shares 10-Q · filed 2018-08-13 | 10.03M shares 10-Q · filed 2018-08-13 | 8.73M shares derived: average of 3 quarters · filed 2018-08-13 | 7.79M shares derived: average of 4 quarters · filed 2018-08-13 | ||||
| 2018-03-31 | 8.68M shares 10-Q · filed 2018-05-14 | 7.38M shares derived: average of 2 quarters · filed 2018-05-14 | 6.58M shares derived: average of 3 quarters · filed 2018-05-14 | 5.16M shares derived: average of 4 quarters · filed 2018-08-13 | ||||
| 2017-12-31 | 6.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | 5.53M shares derived: average of 2 quarters · filed 2018-03-28 | 3.99M shares derived: average of 3 quarters · filed 2018-08-13 | 3.23M shares 10-K · filed 2018-03-28 | ||||
| 2017-09-30 | 4.99M shares 10-Q · filed 2017-11-13 | 2.95M shares derived: average of 2 quarters · filed 2018-08-13 | 2.28M shares 10-Q · filed 2017-11-13 | 1.92M shares derived: average of 4 quarters · filed 2018-08-13 | ||||
| 2017-06-30 | 910.00K shares 10-Q · filed 2018-08-13 | 910.00K shares 10-Q · filed 2018-08-13 | 900.00K shares derived: average of 3 quarters · filed 2018-08-13 | 880.00K shares derived: average of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | 910.00K shares 10-Q · filed 2018-05-14 | 895.00K shares derived: average of 2 quarters · filed 2018-05-14 | 870.00K shares derived: average of 3 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | 880.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | 850.00K shares derived: average of 2 quarters · filed 2018-03-28 | 835.00K shares 10-K · filed 2018-03-28 | |||||
| 2016-09-30 | 820.00K shares 10-Q · filed 2017-11-13 | 820.00K shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |